VANCOUVER, BC – (Marketwired – May 02, 2017) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has completed a non-brokered private placement (the “Placement”) in which it raised gross proceeds of $399,960.
Glen Rehman, President of NeutriSci, stated: “This financing provides us with additional working capital to increase our awareness building programs for neuenergy®. We look forward to participating in more marketing and promotional activities, such as our recent sampling sponsorship at the Vancouver Sun Run, our television ad campaign, and our instore marketing programs.”
The Placement consisted of 3,333,000 units (the “Units”) of the Company at a price of $0.12 per Unit. Each Unit consists of one common share of the Company and one common share purchase warrant, entitling the holder to acquire an additional common share of the Company at a price of $0.20 until November 1, 2018.
In connection with the Placement, the Company paid a cash commission totaling $27,997.20 and issued 233,310 finder’s warrants. Each finder’s warrant entitles the holder to acquire one common share, at a price of $0.20 per share until November 1, 2018. All securities issued in connection with the Placement are subject to a hold period expiring September 3, 2017.
Proceeds of the Placement will be used for marketing and advertising programs related to neuenergy®, and for general corporate purposes.
neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.
To find out more about neuenergy®, please visit www.getneuenergy.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
Tel: (403) 264-6320
For investor relations inquiries:
Skanderbeg Capital Advisors
O: 604‐687‐7130 x105
About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy® contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy® provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.